Other Information.
−Removed: (c) During the quarter ended March 31, 2026, none of our directors or officers adopted or terminated a “ Rule 10b5-1 trading agreement” or a “ non-Rule 10b5-1 trading agreement” (in each case defined in Item 408 of Regulation S-K).
+Added: (c) During the quarter ended June 30, 2026, none of our directors or officers adopted or terminated a “ Rule 10b5-1 trading agreement” or a “ non-Rule 10b5-1 trading agreement” (in each case defined in Item 408 of Regulation S-K).
See the Exhibit Index to this Quarterly Report immediately below and before the signature page hereto, which Exhibit Index is incorporated by reference as if fully set forth herein.
Description of Exhibit
+Added: Business Combination Agreement (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on May 27, 2026)
Amended and Restated Memorandum and Articles of Association of the Company (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on December 27, 2024)
+Added: Amended and Restated Memorandum and Articles of Association of the Company (incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on June 18, 2026)
+Added: Sponsor Letter Agreement (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on May 27, 2026)
+Added: Form of Prologium Shareholder Voting Agreement (incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on May 27, 2026)
+Added: Form of Prologium Shareholder Lock-Up Agreement (incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on May 27, 2026)
+Added: Form of Registration Rights Agreement (incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on May 27, 2026)
+Added: Amendment to Investment Management Trust Agreement, dated as of June 17, 2026, by and between Translational Development Acquisition Corp.
+Added: and Continental Stock Transfer & Trust Company, as trustee.
+Added: (incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities & Exchange Commission on June 18, 2026)
Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
14 unchanged sentences
Translational Development Acquisition Corp.
+Added: August 14, 2026
/s/ Michael B.
1 unchanged sentence
(Principal Executive Officer)
+Added: August 14, 2026
/s/ Avanindra C.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.